Legislation that limits medical research in one state creates uncertainty for research institutions and biotechnology companies across the U.S. Human embryonic stem cell research has been described by scientists as the gold standard for those seeking to develop cures based on stem cell technology for many diseases and maladies such as Parkinson's, ALS, diabetes, MS, macular degeneration and othe